Revenue: The sum of all revenue fields included for a company's operating activities.
NKGen Biotech, Inc. (NKGN) Revenue data is not available for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-82.95M |
|
-- |
|
-- |
|
$29.75M |
|
$-29.75M |
|
$-53.20M |
|
$-82.95M |
|
$-82.95M |
|
$-82.94M |
|
$-82.94M |
|
$-82.94M |
|
$-82.94M |
|
$-29.75M |
|
$-28.54M |
|
15.43M |
|
15.43M |
|
$-5.38 |
|
$-5.38 |
|
| Balance Sheet Financials | |
$1.93M |
|
$14.46M |
|
$14.55M |
|
$16.48M |
|
$39.45M |
|
$9.93M |
|
$35.72M |
|
$75.17M |
|
$-58.69M |
|
$-58.69M |
|
$-58.69M |
|
21.89M |
|
| Cash Flow Statement Financials | |
$-21.95M |
|
$-0.05M |
|
$22.16M |
|
$0.12M |
|
$0.28M |
|
$0.16M |
|
$4.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-0.20 |
|
-0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
141.31% |
|
141.31% |
|
-503.25% |
|
170.09% |
|
$-2.68 |
|
$-1.43 |
|
$-1.42 |
|